AhlforsK., IvarssonS.A., HarrisS., SvanbergL., HolmqvistR., LernmarkB., and TheanderG. (1984). “Congenital cytomegalovirus infection and disease in Sweden and the relative importance of primary and secondary infections.”Scand. J. Infect. Dis.16: 129–137.
2.
ArinD.M., BaumanM.L., and KemperT.L. (1991). “The distribution of Purkinje cell loss in the cerebellum in autism.”Neurology41(suppl): 307.
3.
AshleyD. (1994). “Blood concentrations of volatile organic compounds in a non-occupationally exposed US population and in groups with suspected exposure.”Clin. Chem.40(7): 1401–1404.
4.
BartholomeK., ByrdD.J., KaufmanS., and MilsteinS. (1977). “Atypical phenylketonuria with normal phenylalanine hydroxylase and dihydropteridine reductase activity in vitro.”Pediatrics59: 757–761.
5.
BaumanM.L., and KemperT.L. (1985). “Histoanatomic observations of the brain in early autism.”Neurology35: 866–74.
6.
BearerC. (1995). “How are children different from adults.”Environ. Health Perspect. Sept.,103(Supp 6).
7.
BlackstockE.G. (1978). “Cerebral asymmetry and the development of early infantile autism.”J. Autism Childhood Schizophrenia8: 339–353.
8.
BoltonP., and RutterM. (1990). “Genetic influences in autism.”Int. Rev. Psychiatry2: 67–80.
9.
BossG.R., and SeegmillerJ.E. (1982). “Genetic defects in human purine and pyrimidine metabolism.”Annu. Rev. Genet.16: 297–328.
10.
CantorD.S., ThatcherR.W., KayeH., and HrybykM. (1986). “Computerized EEG analyses of autistic children.”J. Autism Dev. Disord.16: 169–187.
11.
CantuE.S., StoneJ.W., WingA.A., LangeeH.R., and WilliamsC.A. (1990). “Cytogenic survey for autistic fragile-X carriers in a mental retardation center.”Am. J. Mental Retard.94: 442–447.
12.
ChenC.H., and HsiaoK.J. (1989). “A Chinese classic phenylketonuria manifested as autism.”Br. J. Psychiatry155: 251–253.
13.
ChessS. (1977). “Follow-up report on autism in congenital rubella.”J. Autism Childhood Schizophrenia7: 68–81.
14.
CohenI.L., VietzeP.M., SudhalterV., JenkinsE.D., and BrownW.T. (1991). “Effects of age and communication level on eye contact in fragile X males and non-fragile X autistic males.”Am. J. Med. Genet.38: 498–502.
15.
ColemanM. (ed.) (1976). The Autistic Syndromes. North-Holland, Amsterdam; Elsevier, New York.
16.
DaleW.E., CurleyA., and CuetoC. (1966). “Hexane extractable chlorinated insecticides in human blood.”Life Sci.5: 47.
17.
DamasioA.R., and MaurerR.G. (1978). “A neurological model for childhood autism.”Arch. Neurol.35: 777–786.
18.
Davis (1993). “Medical hypothesis: xenoestrogens as preventable causes of breast cancer.”Environ. Health Perspect. October,101(5): 372–377.
19.
DawsonG., WarrenburgS., and FullerP. (1982). “Cerebral lateralization in individuals diagnosed as autistic in early childhood.”Brain and Language15: 353–368.
20.
DelongG.R., BeanS.C., and BrownF.R. (1981). “Acquired reversible autistic syndrome in acute encephalopathic illness in children.”Arch. Neurol.38: 191–194.
DowtyB.J. (1976). “A semi-automated gas chromatographic procedure to analyze fluids.”Anal. Chem.48(6): 946.
23.
DuranM., BeemerF.A., Van De HeidenC., KortelandJ., De BreeP.K., BrinkM., and WadmanS.K. (1978). “Combined deficiency of xanthine oxidase and sulfite oxidase. A defect of molybdenum metabolism or transport?”J. Inherited Metab. Dis.I: 175–178.
24.
FelicettiT. (1981). “Parents of autistic children: some notes on a chemical connection.”Milieu TherapyI: 13–16.
25.
FerioloP. (1989). “Alteration of steroid hormone sulfation and D-glucaric acid excretion in lead workers.”Biol. Trace Elem. Res.21: 289–294.
26.
FolsteinS., and RutterM. (1977). “Infantile autism: a genetic study of 21 twin pairs.”J. Child Psychol. Psychiatry18: 297–321.
27.
FriedmanE. (1969). “The autistic syndrome and phenylketonuria.”Schizophrenia1: 249–261.
28.
GillbergC. (1986). “Brief report: onset at age 14 of a typical autistic syndrome. A case report of a girl with herpes simplex encephalitis.”J. Autism Dev. Disord.16: 369–375.
29.
GillbergC. (1990). “Do children with autism have March birthdays?”Acta Psychiatr. Scand.82: 152–156.
30.
HagermanR.J. (1989). “Chromosomes, genes, and autism.” In: Diagnosis and Treatment of Autism (GillbergC., ed.). Plenum, New York. pp. 105–132.
31.
HaymakerW., PentschewA., MargolesC., and BinghamW.G. (1958). “Occurrence of lesions in the temporal lobe in the absence of convulsive seizures.” In: Temporal Lobe Epilepsy (M. Baldwin and P. Bailey, eds.). C.C. Thomas, Springfield, IL. pp. 166–202.
32.
HuntA., and DennisJ. (1987). “Psychiatric disorders among children with tuberous sclerosis.”Dev. Med. Child Neurol.29: 190–98.
33.
HunterJ. (1971). “Urinary D-glucaric acid excretion as a test for hepatic enzyme induction in man.”Lancet699: 572–575.
34.
JaekenJ., and Van De BergheG. (1984). “An infantile autistic syndrome characterized by the presence of succinylpurines in body fluids.”Lancet2: 1058–1061.
35.
JamesA.L., and BarryR.J. (1981). “General maturational lag as an essential correlate of early-onset psychosis.”J. Autism Dev. Disord.11: 271–283.
36.
KalfG.F., RushmoreT., and SnyderR. (1982). “Benzene inhibits RNA synthesis in mitochondria from liver and bone marrow.”Chem. Biol. Interact.42: 353–370.
37.
KannerL. (1943). “Autistic disturbances of affective contact.”Nerv. Child.2: 217–250.
38.
KotsopoulosS., and KuttyK.M. (1979). “Histidinemia and infantile autism.”J. Autism Dev. Disord.9: 55–60.
39.
LittleJ. (1986). The Most Frequently Observed PCB Congeners in Human Blood Serum.Verbal, CDC.
40.
MarchJ. (1978). “Values for urinary excretion of D-glucaric acid excretion by normal individuals.”Clin. Chem.20/9: 1155–1158.
41.
MccannB.S. (1981). “Hemispheric asymmetries and early infantile autism.”J. Autism Dev. Disord.11: 401–411.
42.
McdougleC.J. (1996). “Effects of tryptophan depletion in drug-free adults with autistic disorder.”Arch. Gen. Psychiatry53: 993–1000.
43.
NiswanderK.R., and GordonM. (1972). “The Women and their Pregnancies.”US Government Printing Office, Washington, DC (DHEW pub. no. 73-379).
44.
NottenW.R.P., and HendersonP.T. (1977). “The interaction of chemical compounds with the functional state of the liver.”Int. Arch. Occup. Environ. Health38: 209–220.
45.
O'REILLYB., WaringR.H. (1993). “Enzyme and sulfur oxidation defiencies in autistic children with known food and chemical intolerances.”J. Orthomolecular Med. Dec.,8(4).
46.
PangbornJ.B. (1984). Detection and treatment of metabolic dysfunctions related to disordered immune response in autistics. Proceedings of Annual Meeting of National Society for Children Adults with Autism. July 8-14, 1984. San Antonio, TX.
47.
PlioplysA.-V. (1994). “Lymphocyst function in autism and Rett syndrome.”Neuropsychobiology29(1): 12–6.
48.
ReaW.J., ButlerR., LaseterJ.L., and DeleonI.R. (1984). “Pesticides and brain functional changes in a controlled environment.”Clinical Ecology, Summer, II (3).
49.
RitvoE.R., FreemanB.J., Mason-BrothersA., MoA., and RitvoA.M. (1985). “Concordance of the syndrome of autism in 40 pairs of afflicted twins.”Am. J. Psychiatry142: 74–77.
50.
ShihV.E., and MadiganP.M. (1974). “Routine newborn screening of histidinemia.”New Engl. J. Med.191: 1214–1219.
51.
SinghV.K. (1991). “Changes of soluble interleukin-2, interleukin-2 receptor, T8 antigen and interleukin-1 in the serum of autistic children.”Clin. Immunol. Immunopathol.61: 448–455.
52.
SinghV.K., ColeP., OdellJ.D., PingreeC.B., WarrenW.L., and WhiteE. (1991). “Increased frequency of the null allele at the C4b locus in autism.”Clin. Exp. Immunol.83: 438–440.
53.
SinghV.L. (1993). “Antibodies to myelin basic protein in children with autistic behavior.”Brain, Behavior, and Immunity Mar.,7(1): 97–103.
54.
SlikkenW.Jr., and GaylorD.W. (1995). “Risk assessment strategies for neuroprotective agents.”Ann. New York Acad. Sci. Sept., 15;765: 198–208.
55.
StubbsE.G. (1978). “Autistic symptoms in a child with congenital cytomegalovirus infection.”J. Autism Childhood Schizophrenia8: 37–43.
56.
StubbsE.G., CrawfordM.L., BurgerD.R., and VanderbrookA.A. (1977). “Depressed lymphocyte responsiveness in autistic children.”J. Autism Childhood Schizophrenia7: 49–55.
57.
TilsonH.A.“The concern for developmental neurotoxicology: is it justified and what is being done about it?”Neurotoxicology Division, HERL EPA, Research Triangle Park, NC 27711, USA.
58.
TorreyE.F., HershS.P., MccabeK.D. (1975). “Early childhood psychosis and bleeding during pregnancy: a prospective study of gravid women and their offspring.”J. Autism Childhood Schizophrenia5: 287–297.
59.
WarrenR.P. (1955). “DR-positive T cells in autism: association with decreased plasma levels of the complement C4B protein.”Neuropsychobiology31(2): 53–57.
60.
YonkJ.L. (1990). “CD4 helper T cell depression in autism.”Immunol. Lett.25: 3241–346.
61.
YuM.L. (1991). “In utero PCB/PCDF exposure: Relation of developmental delay to dsymorphology and dose.”Neurotoxicol. Teratol.13: 195–202.